Cawachi Limited
Notice Regarding Partial Amendment of Articles of Incorporation
Proposal to amend the Articles of Incorporation to shorten the term of directors from the current two years to one year, to be submitted at the shareholders meeting on June 11, 2026.
Key Figures
- Term of Directors: shortened to one year (currently two years)
- Effective Date of Articles of Incorporation Amendment: 2026-06-11
- Scheduled Date for the 59th Annual Shareholders Meeting: 2026-06-11
AI要約
Outline of the Amendment to the Articles of Incorporation
Kawachi Pharmaceutical Co., Ltd. has resolved a partial amendment to the Articles of Incorporation to shorten the term of directors from the current two years to one year, aiming to clarify management responsibility, establish a management structure capable of swift response to changes in the business environment, and strengthen corporate governance. This amendment will be submitted at the 59th Annual Shareholders Meeting scheduled for June 11, 2026, and is expected to take effect on the same day.
Regarding the Shareholders Meeting and Transitional Measures
The shareholders meeting to approve the amendment to the Articles of Incorporation is scheduled for June 11, 2026. As a transitional measure, the term of directors appointed at the 58th Annual Shareholders Meeting held on June 11, 2025 is set to continue until the conclusion of the 60th Annual Shareholders Meeting scheduled for June 2027. This measure coordinates the expiration timing of the current directors' terms.
Kawachi Pharmaceutical Co., Ltd.
Company overview · Stock price · Financial data · All IR
